Quinn Opportunity Partners’s Adverum Biotechnologies ADVM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $89K | Hold |
41,418
| – | – | 0.01% | 317 |
|
|
2025
Q1 | $181K | Buy |
41,418
+14,589
| +54% | +$63.8K | 0.01% | 332 |
|
|
2024
Q4 | $125K | Hold |
26,829
| – | – | 0.01% | 329 |
|
|
2024
Q3 | $188K | Hold |
26,829
| – | – | 0.02% | 232 |
|
|
2024
Q2 | $184K | Hold |
26,829
| – | – | 0.02% | 222 |
|
|
2024
Q1 | $379K | Sell |
26,829
-13,001
| -33% | -$184K | 0.04% | 177 |
|
|
2023
Q4 | $300K | Hold |
39,830
| – | – | 0.03% | 170 |
|
|
2023
Q3 | $597K | Hold |
39,830
| – | – | 0.08% | 142 |
|
|
2023
Q2 | $633K | Hold |
39,830
| – | – | 0.09% | 127 |
|
|
2023
Q1 | $286K | Hold |
39,830
| – | – | 0.03% | 186 |
|
|
2022
Q4 | $231K | Sell |
39,830
-2,000
| -5% | -$11.6K | 0.03% | 154 |
|
|
2022
Q3 | $397K | Sell |
41,830
-8,470
| -17% | -$80.5K | 0.05% | 137 |
|
|
2022
Q2 | $604K | Hold |
50,300
| – | – | 0.05% | 139 |
|
|
2022
Q1 | $659K | Hold |
50,300
| – | – | 0.03% | 124 |
|
|
2021
Q4 | $885K | Buy |
50,300
+25,500
| +103% | +$449K | 0.05% | 144 |
|
|
2021
Q3 | $538K | Hold |
24,800
| – | – | 0.03% | 194 |
|
|
2021
Q2 | $868K | Buy |
+24,800
| New | +$868K | 0.05% | 165 |
|